Kestra Medical Technologies Inc (KMTS)

Kestra Medical Technologies Inc. is a healthcare equipment and supplies company listed on NASDAQ under the ticker KMTS. The company develops wearable medical devices and connected digital healthcare solutions, with a focus on cardiovascular care. Its Cardiac Recovery System platform combines monitoring, therapeutic intervention, digital health tools, and patient support services in a unified offering. The platform includes ASSURE WCD, a wearable cardioverter defibrillator designed for patients at elevated risk of sudden cardiac arrest, along with integrated digital solutions that support patient and provider engagement and oversight. Founded in 2014 and based in Kirkland, Washington, Kestra Medical Technologies operates as a common equity issuer in the healthcare sector.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-KMTS
$19.44
-20.4% Downside
Overvalued
$30.29
24.0% Upside
Undervalued
Fair
0.0%
December 10, 2026
6.5x
13.6x
1.453 B
1.282 B
5.0%
56.6%
3.7
82.2%
Valuation • Fair Value

Kestra Medical Technologies Inc (NASDAQ-KMTS) Fair Value by Valuation Model

Review the available estimates for Kestra Medical Technologies Inc (NASDAQ-KMTS), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$19.44

Estimated downside of 20.4% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$19.46

Discounted cash flow valuation reference.

Comps Fair Value

$19.44

Comparable-company valuation reference.

Analyst Price Target

$30.29

Analysts imply upside of 24.0%.

How to read these valuation models

Use the 5 available valuation references for Kestra Medical Technologies Inc (NASDAQ-KMTS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Kestra Medical Technologies Inc (NASDAQ-KMTS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

106.7 M

Current operating scale indicator.

Revenue Forecast

141 M

Forward revenue estimate.

EBITDA

-134.2 M

Current operating profitability reference.

EBITDA Forecast

-85.835 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Kestra Medical Technologies Inc (NASDAQ-KMTS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Kestra Medical Technologies Inc (NASDAQ-KMTS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

1.99

Higher caution zone on this screen.

Altman Z-Score

3.7

Relatively strong balance-sheet zone.

FCF / Net Income

82.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Kestra Medical Technologies Inc (NASDAQ-KMTS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Kestra Medical Technologies Inc (NASDAQ-KMTS)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 10, 2026

Days to Earnings

83

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Kestra Medical Technologies Inc (NASDAQ-KMTS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Kestra Medical Technologies Inc (NASDAQ-KMTS) Stock Forecast & Technical Outlook

Review Kestra Medical Technologies Inc (NASDAQ-KMTS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Kestra Medical Technologies Inc (NASDAQ-KMTS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Kestra Medical Technologies Inc (NASDAQ-KMTS) has a Strong Buy consensus, with 5 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 1
Sell 0
FAQ Fast Investor Answers

Kestra Medical Technologies Inc (NASDAQ-KMTS) Stock FAQ

Data-supported answers about Kestra Medical Technologies Inc (NASDAQ-KMTS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$19.44
Estimated downside 20.4%
Valuation Rating
Overvalued
Estimated downside of 20.4%
Analyst Target
$30.29
Implied upside 24.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Kestra Medical Technologies Inc (NASDAQ-KMTS) is $19.44. This implies an estimated downside of 20.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 20.4% versus the current market price.

The available analyst price target for Kestra Medical Technologies Inc (NASDAQ-KMTS) is $30.29. The analyst target implies estimated upside of 24.0%.

The current financial health read for Kestra Medical Technologies Inc (NASDAQ-KMTS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Kestra Medical Technologies Inc (NASDAQ-KMTS) is December 10, 2026.

The latest available data indicates no current dividend yield for Kestra Medical Technologies Inc (NASDAQ-KMTS).

The current market capitalization listed for Kestra Medical Technologies Inc is 1.453 B.

The current enterprise value listed for Kestra Medical Technologies Inc is 1.282 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Kestra Medical Technologies Inc is NASDAQ-KMTS, and the stock is listed on NASDAQ.

Kestra Medical Technologies Inc (NASDAQ-KMTS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Kestra Medical Technologies Inc is 5.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Kestra Medical Technologies Inc is 56.6%. Free float helps investors understand how much of the share base is available for public trading.